A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 12, Issue 5, Pages 595-602
Publisher
Informa UK Limited
Online
2016-02-23
DOI
10.1586/1744666x.2016.1155452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease
- (2015) S. Jolles et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study
- (2015) Alessandra Vultaggio et al. CLINICAL DRUG INVESTIGATION
- A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiency
- (2014) Richard L Wasserman Expert Review of Clinical Immunology
- Immunoglobulin replacement therapy for primary immunodeficiencies
- (2014) Jonathan G Peter et al. Immunotherapy
- Intravenous and Subcutaneous Immunoglobulin Replacement: A Two-Way Road. Optimizing Healthcare Quality in Patients with Primary Immunodeficiencies
- (2014) Pere Soler-Palacín et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
- (2014) Hirokazu Kanegane et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push
- (2013) R. Shapiro CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina
- (2013) Liliana Bezrodnik et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Newborn screening for primary immunodeficiencies: beyond SCID and XLA
- (2012) Stephan Borte et al. Annals of the New York Academy of Sciences
- Guidelines for newborn screening of primary immunodeficiency diseases
- (2012) Stephan Borte et al. CURRENT OPINION IN HEMATOLOGY
- Immune Globulin Subcutaneous (Human) 20%
- (2012) Paul L. McCormack DRUGS
- Efficacy, Safety and Pharmacokinetics of a Novel Subcutaneous Immunoglobulin, Evogam®, in Primary Immunodeficiency
- (2012) Marianne B. Empson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Home-Based Subcutaneous Immunoglobulin Versus Hospital-Based Intravenous Immunoglobulin in Treatment of Primary Antibody Deficiencies: Systematic Review and Meta Analysis
- (2012) Hassan Abolhassani et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy
- (2011) S. Jolles et al. CLINICAL IMMUNOLOGY
- Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency
- (2011) Richard L. Wasserman et al. CLINICAL PHARMACOKINETICS
- Indications and safety of intravenous and subcutaneous immunoglobulin therapy
- (2011) Nima Rezaei et al. Expert Review of Clinical Immunology
- Efficacy, Safety, and Pharmacokinetics of a 10% Liquid Immune Globulin Preparation (GAMMAGARD LIQUID, 10%) Administered Subcutaneously in Subjects with Primary Immunodeficiency Disease
- (2011) Richard L. Wasserman et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
- (2011) Michael Borte et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Efficacy and Safety of Subcutaneous Vivaglobin® Replacement Therapy in Previously Untreated Patients with Primary Immunodeficiency: A Prospective, Multicenter Study
- (2011) Michael Borte et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease
- (2010) R. L. Wasserman et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
- (2010) John B. Hagan et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Subcutaneous Immunoglobulin Therapy by Rapid Push is Preferred to Infusion by Pump: A Retrospective Analysis
- (2010) Ralph Shapiro JOURNAL OF CLINICAL IMMUNOLOGY
- Economic Assessment of Different Modalities of Immunoglobulin Replacement Therapy
- (2008) Stephen K. Membe et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency
- (2008) Melvin Berger IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Prospective Study on CVID Patients with Adverse Reactions to Intravenous or Subcutaneous IgG Administration
- (2008) Isabella Quinti et al. JOURNAL OF CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now